refer
avail
onlin
wwwexpertconsultcom
bronchiol
diseas
primarili
first
year
life
charac
teriz
sign
symptom
obstruct
airway
diseas
caus
commonli
virus
approxim
infant
first
month
life
hospit
bron
chioliti
account
approxim
hospit
death
annual
unit
state
data
center
diseas
control
prevent
cdc
indic
number
yearli
hospit
admiss
attribut
bronchiol
increas
twofold
increas
surviv
rate
prematur
infant
well
infant
compromis
cardiac
pulmonari
immun
statu
increas
number
children
risk
sever
bronchiol
mani
virus
caus
bronchiol
although
respiratori
syn
cytial
viru
rsv
human
metapneumoviru
parainfluenza
viru
type
common
etiolog
agent
virus
implic
less
frequent
tabl
winter
month
rsv
identifi
etiolog
agent
cell
cultur
antigen
detect
assay
children
ho
pital
bronchiol
pneumonia
epidem
bronchi
oliti
earli
spring
fall
often
caus
parainfluenza
viru
type
yearli
cycl
respiratori
virus
depict
figur
viral
caus
bronchiol
includ
rhinovirus
coronavirus
bordetella
pertussi
mycoplasma
pneumonia
measl
influenza
adenoviru
associ
sever
form
bron
chioliti
bronchiol
obliteran
uncommon
obstruct
pulmonari
diseas
character
histolog
progr
sion
acut
airway
inflamm
necrosi
cell
line
lumen
sever
oblit
fibrosi
final
stage
pathogenesi
bronchiol
obliteran
probabl
differ
simpl
viral
bronchiol
bronchiol
may
defin
episod
obstruct
lower
airway
diseas
precipit
viral
infect
infant
younger
month
age
peak
incid
sever
diseas
occur
month
age
rate
hospit
higher
boy
among
infant
live
industri
urban
set
rather
rural
set
hospit
rate
time
higher
among
infant
children
highrisk
group
among
nonhighrisk
infant
highrisk
group
includ
prematur
infant
week
gestat
infant
born
hemodynam
signific
congenit
heart
diseas
well
infant
chronic
lung
diseas
prematur
previous
call
bronchopulmonari
dysplasia
although
mortal
reduc
recent
year
morbid
among
highrisk
patient
high
averag
hospit
length
stay
intens
care
sever
time
previous
healthi
infant
occurr
respiratori
viru
season
predict
even
though
sever
season
date
onset
peak
activ
end
season
predict
preci
sion
variat
time
commun
outbreak
diseas
due
rsv
year
year
commun
among
neighbor
commun
even
season
us
commun
south
tend
experi
earliest
limit
number
case
bronchiol
occur
summer
earli
fall
like
caus
virus
rsv
rhinoviru
parainfluenza
virus
case
gener
milder
rsvrelat
case
tropic
coun
tri
annual
epidem
rsv
coincid
raini
season
winter
although
sporad
case
occur
throughout
year
rsv
divid
b
strain
numer
subtyp
genotyp
type
strain
may
associ
commonli
epidem
sever
diseas
higher
hospitali
zation
rate
type
b
strain
although
studi
consist
ent
regard
differ
sever
strain
may
circul
season
infant
may
reinfect
within
year
progress
increas
hospit
rate
bronchiol
us
occur
sinc
late
increas
may
relat
greater
abil
identifi
hypox
infant
use
puls
oximetri
altern
increas
hospitaliza
tion
may
reflect
increas
use
daycar
center
chang
criteria
admiss
household
crowd
import
risk
factor
sever
viral
lower
respiratori
tract
ill
due
rsv
well
respiratori
virus
gener
recogn
number
household
member
increas
risk
expo
sure
infecti
respiratori
secret
also
increas
childcar
attend
correl
increas
risk
bronchi
oliti
studi
unlik
respiratori
viru
infect
exposur
passiv
household
tobacco
smoke
asso
ciat
increas
risk
rsv
hospit
consist
ent
basi
contrast
welldocu
benefici
effect
breastfeed
viral
ill
exist
data
con
flict
regard
specif
protect
effect
breastfeed
rsv
infect
parent
histori
bronchiol
week
onset
rsv
activ
midwest
tend
experi
latest
onset
durat
season
west
northeast
typic
south
midwest
nevertheless
variat
occur
within
overal
pattern
rsv
outbreak
usual
begin
novemb
decemb
peak
januari
februari
end
end
march
april
refer
avail
onlin
wwwexpertconsultcom
asthma
associ
higher
risk
develop
lower
respiratori
ill
offspr
young
chronolog
age
begin
rsv
season
consist
risk
factor
rsv
hospit
sever
reason
may
account
increas
risk
sever
rsv
diseas
occur
first
month
life
birth
shortli
earli
onset
rsv
season
result
longer
period
exposur
rsv
earlier
life
second
matern
antibodi
concen
tration
rsv
show
season
variat
infant
born
earli
rsv
season
like
born
mother
low
serum
antibodi
concentr
f
fusion
protein
rsv
low
concentr
rsv
antibodi
correl
suscept
sever
rsv
diseas
infant
acut
bronchiol
gener
impli
diseas
infecti
etiolog
usual
due
virus
specif
tropism
bronchiolar
epi
thelium
healthi
infant
recov
bronchiol
without
incid
inform
regard
patholog
chang
caus
infect
infer
anim
studi
biopsi
autopsi
materi
sever
case
viral
infect
caus
profound
alter
epitheli
cell
mucos
surfac
human
respiratori
tract
characterist
histopatholog
bronchiol
lymphocyt
infiltr
bronchiolar
wall
edema
surround
tissu
diseas
progress
asso
ciat
prolifer
necrosi
bronchiolar
epith
lium
slough
necrot
epithelium
increas
mucu
product
lead
obstruct
lumen
infant
small
airway
air
movement
restrict
inspir
expira
tion
restrict
expir
lumen
compromis
posit
expiratori
pressur
result
expiratori
wheez
obstruct
result
air
trap
characterist
appear
hyperinfl
chest
radio
graph
air
absorb
radiograph
pattern
evolv
show
atelectasi
presenc
high
serum
concentr
immunoglobulin
igg
antibodi
rsv
whether
transplacent
acquir
administ
intramuscularli
amelior
rsv
ill
sever
obstruct
ill
may
relat
stimul
virusspecif
igemedi
hypersensit
respons
alter
cellmedi
immun
respons
bronchiol
repres
late
stage
respiratori
diseas
progress
sever
day
upper
respiratori
tract
symptom
consist
nasal
discharg
mild
cough
begin
day
onset
infect
approxim
rsv
infect
infant
progress
diseas
involv
lower
respiratori
tract
spread
lower
airway
occur
either
aspi
ration
rsvinfect
epitheli
cell
celltocel
spread
viru
lowerairway
involv
mark
sudden
increas
work
breath
cough
tachypnea
wheez
crackl
use
accessori
muscl
nasal
flare
respi
ratori
rate
often
exce
breathsminut
young
infant
expir
prolong
intercost
subcost
retract
wheez
evid
initi
wheez
occur
expiratori
phase
audibl
stethoscop
wheez
progress
heard
without
stethoscop
chest
becom
hyperexpand
hyperreson
respir
labor
retract
sever
hypoxemia
proport
clinic
distress
typic
rsv
infect
mild
hypoxemia
occur
even
otherwis
wellappear
infant
socal
happi
wheezer
respiratori
failur
due
hypox
emia
earli
sometim
sudden
occurr
progress
hypercapnia
due
fatigu
small
airway
young
infant
becom
narrow
wheez
inaud
set
diseas
sever
recogn
absenc
audibl
air
exchang
flare
ala
nasa
expiratori
grunt
sever
subcost
supraclavicular
intercost
retract
hypox
emia
progress
ill
often
accompani
rapid
fall
oxygen
satur
minim
manipul
child
find
usual
requir
intub
ventilatori
support
apnea
earli
manifest
rsv
infect
time
result
respiratori
failur
rsvrelat
apnea
mediat
central
nervou
system
occur
young
often
prematur
born
infant
sever
bronchiol
often
wax
wane
prior
consist
improv
assess
respira
tori
statu
vari
markedli
short
period
abil
young
infant
breast
bottlefe
without
distress
time
often
provid
practic
guid
diseas
sever
man
agement
infant
substanti
difficulti
feed
result
respiratori
distress
moder
sever
ill
usual
requir
hospit
otherwis
healthi
infant
younger
month
age
infant
born
prematur
less
week
gestat
infant
chronic
lung
diseas
prematur
previous
call
broncho
pulmonari
dysplasia
infant
born
congenit
heart
diseas
highest
morbid
mortal
rate
due
bronchiol
infant
born
congenit
heart
diseas
greatest
risk
hospit
due
bronchiol
includ
moder
sever
pulmonari
hypertens
infant
cyanot
heart
diseas
rsvinfect
infant
children
follow
hemodynam
insignific
heart
diseas
gener
alli
consid
increas
risk
hospit
secundum
atrial
septal
defect
small
ventricular
septal
defect
pulmon
stenosi
uncompl
aortic
stenosi
mild
coarcta
tion
aorta
patent
ductu
arteriosu
well
infant
lesion
adequ
correct
surgeri
unless
continu
requir
medic
manag
congest
heart
failur
sever
respiratori
distress
bronchiol
present
manifest
previous
unrecogn
con
genit
heart
diseas
hospit
rsvinfect
infant
may
highli
variabl
cours
ill
among
otherwis
healthi
infant
intens
care
unit
admiss
respiratori
deterior
uncommon
decis
admit
intens
care
unit
base
possibl
need
intub
progress
hypercapnia
increas
hypoxemia
despit
supplement
oxygen
apnea
typic
cours
previous
healthi
infant
older
month
one
improv
day
evi
denc
decreas
respiratori
rate
retract
durat
expir
oxygen
requir
median
durat
symptom
infant
firsttim
bronchiol
came
medic
attent
emerg
depart
wisconsin
day
onequart
infant
remain
symptomat
week
pulmonari
function
abnorm
evid
mild
desatur
oxygen
satur
rang
persist
sever
week
differenti
diagnosi
bronchiol
includ
airway
hypersensit
environment
irrit
anatom
abnorm
airway
cardiac
diseas
pulmonari
edema
cystic
fibrosi
foreignbodi
aspir
gastroesophag
reflux
diagnosi
bronchiol
base
clinic
criteria
support
radiograph
find
typic
chest
radiograph
find
ing
hyperinfl
flatten
diaphragm
hyperluc
lung
patchi
atelectasi
especi
involv
right
upper
lobe
figur
atel
ectasi
due
airway
narrow
mucou
plug
associ
volum
loss
may
confus
lobar
con
solid
aspir
pneumonia
gener
volumeexpand
lesion
bacteri
pneumonia
infrequ
occur
complic
bronchiol
suspect
infant
fever
persist
day
lack
respons
support
manag
establish
specif
etiolog
diagnosi
help
predict
ing
clinic
cours
cohort
hospit
may
becom
increasingli
use
antivir
agent
effect
respiratori
virus
becom
avail
although
viral
cultur
respiratori
secret
gold
standard
revers
transcriptionpolymeras
chain
reactionenzym
hybridi
zation
assay
hexaplex
avail
test
singl
nasopharyng
sampl
rsv
influenza
b
virus
parainfluenza
viru
adenovirus
antigen
detect
test
use
diagnos
certain
viral
infect
test
posit
predict
valu
decreas
diseas
incid
goe
specif
antigen
detect
assay
lowest
season
onset
end
respiratori
viru
season
infant
bronchiol
manag
home
support
care
hypoxia
inabl
feed
adequ
nece
sitat
hospit
hospit
infant
respond
administr
supplement
oxygen
replac
fluid
deficit
valu
mist
inhal
vapor
tent
proven
use
provok
reflex
bronchoconstrict
spe
cific
treatment
strategi
use
differ
wide
across
children
medic
center
fewer
previous
healthi
infant
hospit
bronchiol
requir
intub
mechan
ventil
respiratori
failur
apnea
percentag
higher
prematur
born
infant
infant
chronic
lung
diseas
congenit
heart
malform
therapeut
role
bronchodil
agent
bronchiol
controversi
bronchodil
therapi
recommend
routin
manag
first
time
wheez
associ
rsv
bronchiol
occasion
singl
administr
aero
soliz
bronchodil
elicit
respons
improv
seen
infant
bronchiol
gener
reproduc
subsequ
dose
modest
improv
clinic
score
test
pulmonari
function
report
use
inhal
racem
epinephrin
agent
princip
salbutamol
albuterol
howev
clinic
improv
follow
repeat
dose
epin
phrine
sustain
favor
respons
agent
measur
clinic
score
oxygen
inconsist
flore
horwitz
perform
metaanalysi
eight
studi
similar
design
overal
analysi
sup
port
benefici
effect
certain
infant
identifi
infant
could
consist
accomplish
time
initi
present
balanc
initi
trial
bronchodil
therapi
hospit
infant
bronchiol
reasona
ble
although
brief
episod
hypoxia
precipit
adrenerg
agent
bronchodil
therapi
contin
u
consist
improv
respiratori
distress
oxygen
satur
observ
racem
epinephrin
con
tinu
beyond
one
two
dose
although
corticosteroid
reduc
inflammatori
chang
observ
bronchiol
may
increas
viral
replic
prolong
shed
studi
examin
role
corti
costeroid
alon
treatment
bronchiol
demonstr
consist
clinic
benefit
although
one
metaanalysi
previous
publish
report
corticosteroid
use
bronchiol
conclud
may
slight
improv
durat
symptom
length
hospit
stay
clinic
score
benefit
appear
limit
routin
use
corticosteroid
bronchiol
recommend
howev
nation
collabor
blind
placebocontrol
trial
con
duct
canada
demonstr
combin
neb
uliz
epinephrin
oral
dexamethason
treatment
children
bronchiolit
evalu
emerg
depart
reduc
subsequ
rate
hospit
compar
placebo
either
treatment
alon
less
costli
diagnosi
rsv
infect
often
slow
method
clinic
use
enzym
immunoassay
direct
fluoresc
antibodi
dfa
techniqu
identif
rsv
influenza
viru
parainfluenza
virus
adenovirus
permit
rapid
accur
diagnos
nasal
wash
prefer
method
specimen
collect
dfa
test
permit
evalu
adequaci
specimen
number
epitheli
cell
antigen
detect
respiratori
screen
nasal
secret
use
pool
mono
clonal
antibodi
common
agent
bronchiol
follow
specif
identif
posit
reaction
cost
timesav
procedur
compar
standard
tissu
cultur
iso
lation
amplif
viru
use
shell
vial
method
fol
low
use
specif
monoclon
agent
amplif
viral
genom
polymeras
chain
reaction
offer
promis
improv
sensit
rapid
detect
wide
avail
rapid
enzym
immunoassay
fluoresc
antibodi
techniqu
multitest
system
quantit
infanc
increas
likelihood
childhood
asthma
numer
ou
studi
defin
higher
risk
recurr
wheez
throughout
childhood
bronchiol
infanc
abnor
maliti
smallairway
function
identifi
school
age
children
histori
bronchiol
infanc
howev
find
may
simpli
reflect
hereditari
tendenc
express
time
bronchiol
upon
allergen
exposur
later
childhood
moreov
adolesc
rate
recurr
wheez
subject
bronchiol
infanc
appear
fall
rate
observ
subject
without
histori
bronchiol
thu
uncertain
whether
bronchiol
causal
associ
longterm
respi
ratori
morbid
strategi
reduc
contact
vulner
infant
individu
al
respiratori
tract
infect
minim
passiv
exposur
cigarett
smoke
limit
nosocomi
transmiss
cau
ativ
agent
offer
immedi
opportun
reduc
bronchiol
morbid
monthli
administr
monoclon
antif
anti
bodi
palivizumab
throughout
rsv
season
reduc
inci
denc
hospit
due
rsv
infect
infant
bronchopulmonari
dysplasia
congenit
heart
diseas
pre
matur
see
chapter
respiratori
syncyti
viru
high
cost
modest
effect
palivizumab
limit
use
passiv
immunoprophylaxi
medic
fragil
infant
vaccin
prevent
infect
rsv
parainfluenza
virus
common
caus
bronchiol
licens
near
licensur
trival
influenza
vaccin
recommend
infant
older
month
age
influenza
season
approv
use
infant
younger
month
routin
influenza
vaccin
import
famili
member
caregiv
young
patient
potenti
rsv
vaccin
candid
current
evalu
includ
inactiv
prepar
purifi
fusion
protein
rsv
dna
vaccin
code
major
immunogen
protein
viru
rep
licat
mutant
viru
replic
upper
respiratori
tract
inactiv
higher
temperatur
lung
ribavirin
nucleosid
analogu
vitro
activ
rsv
adenoviru
influenza
b
virus
parainfluenza
virus
earli
trial
indic
ribavirin
therapi
associ
modest
improv
clinic
score
oxygen
durat
mechan
ventil
infant
sever
bron
chioliti
due
rsv
infect
studi
challeng
basi
control
group
receiv
water
aerosol
may
produc
bronchospasm
individu
hyperreact
airway
clinic
trial
ribavirin
demonstr
consist
decreas
need
mechan
ventil
decreas
length
stay
intens
care
unit
reduct
day
hospitaliza
tion
conflict
result
efficaci
trial
concern
poten
tial
toxic
effect
among
expos
healthcar
profession
aerosol
rout
administr
high
cost
result
limit
use
ribavirin
guidelin
use
ribavirin
rsv
diseas
present
chapter
respiratori
syncyti
viru
potenti
option
treatment
bronchiol
caus
influenza
b
virus
discuss
chapter
influ
enza
virus
immun
globulin
therapi
antibodi
prepar
contain
high
titer
neutral
anti
bodi
rsv
well
prepar
monoclon
antibod
i
direct
one
two
major
rsv
surfac
glycoprotein
fusion
glycoprotein
reduc
risk
hospit
due
rsv
infect
use
therapeut
result
rapid
clear
ing
viru
respiratori
tract
alter
cours
ill
use
treatment
rsv
infect
although
vitamin
level
demon
strate
low
infant
rsv
bronchiol
therapeut
benefit
vitamin
therapi
demonstr
otherwis
healthi
infant
recov
complet
acut
bronchiol
although
subtl
pulmonari
abnorm
persist
week
